Nordea Investment Management
DNA icon

Nordea Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Nordea Investment Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-93,293
Closed -$1.3M – 905
2024
Q2 		$1.3M Sell
93,293
-15,966
-15% -$476K ﹤0.01% 773
2024
Q1 		$5.18M Sell
109,259
-1,052
-1% -$54.5K 0.01% 531
2023
Q4 		$7.43M Buy
110,311
+5,410
+5% +$331K 0.01% 451
2023
Q3 		$7.76M Buy
104,901
+18,186
+21% +$1.45M 0.01% 413
2023
Q2 		$6.49M Buy
+86,715
New +$5.13M 0.01% 465

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Nordea Investment Management's DNA Position: Q3 2024 in Review

Nordea Investment Management sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 93,293 shares — an estimated $1.3M sold.

Nordea Investment Management first reported a position in DNA in Q2 2023 and held it in 5 quarters. The position peaked at $7.76M in Q3 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Nordea Investment Management reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Nordea Investment Management sold 93,293 Ginkgo Bioworks shares in Q3 2024, an estimated $1.3M.
  • Nordea Investment Management first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 5 quarters.
  • Nordea Investment Management's Ginkgo Bioworks position peaked at $7.76M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Nordea Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.